Iterum Therapeutics PLC (ITRM)

Name: Iterum Therapeutics PLC (ITRM) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Iterum Therapeutics PLC (ITRM)

Stock Card

$0.06

$-0.02 (-23.92%)

As on 02-Jun-2026 09:30EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.4

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

Iterum Therapeutics PLC (ITRM) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.05 High: 0.08

52 Week Range

Low: 0.01 High: 1.28

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-5.6 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

0.5
Debt to Equity

-4.5
Book Value

$--
EPS

$-0.8
Face value

--
Shares outstanding

53,291,578

8 Years Aggregate

CFO

$-324.85 Mln

EBITDA

$-361.17 Mln

Net Profit

$-449.43 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Iterum Therapeutics PLC (ITRM)	-82.1	53.3	-77.3	-94.0	-63.0	-69.5	--
BSE Sensex^*	-9.1	-1.2	2.9	-3.6	5.7	6.2	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 02-Jun-2026 | *As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2025	2023	2022	2021	2020	2019
Iterum Therapeutics PLC (ITRM)	-81.1	134.5	-85.7	-60.4	-78.0	-10.2
S&P Small-Cap 600	4.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Iterum Therapeutics PLC (ITRM)	0.1	1.6	0.4	-27.0	-6,253.1	--	--	0.4
Alkermes (ALKS)	47.0	7,953.7	1,667.7	66.1	9.4	3.6	128.1	4.5
GH Research PLC (GHRS)	27.0	1,917.9	0.0	-62.3	--	-19.5	--	5.5
Prothena (PRTA)	9.4	479.0	54.5	-44.0	-80.0	-15.5	--	1.6

Shareholding Pattern

View Details

About Iterum Therapeutics PLC (ITRM)

Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of... uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Read more

President, CEO & Director

Mr. Corey N. Fishman
President, CEO & Director

Mr. Corey N. Fishman
Headquarters

Dublin
Website

https://www.iterumtx.com

FAQs for Iterum Therapeutics PLC (ITRM)

What is the current share price of Iterum Therapeutics PLC (ITRM) Today?

The share price of Iterum Therapeutics PLC (ITRM) is $0.06 (NASDAQ) as of 02-Jun-2026 09:30 EDT. Iterum Therapeutics PLC (ITRM) has given a return of -63.04% in the last 3 years.

What is the current PB & PE ratio of Iterum Therapeutics PLC (ITRM)?

Since, TTM earnings of Iterum Therapeutics PLC (ITRM) is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2024	-1.41	-8.54
2023	-0.68	-4.06
2022	-0.25	0.40
2021	-0.06	0.10
2020	-0.05	-0.05

What is the 52 Week High and Low of Iterum Therapeutics PLC (ITRM)?

The 52-week high and low of Iterum Therapeutics PLC (ITRM) are Rs 1.28 and Rs 0.01 as of 01-Sep-2026.

What is the market cap of Iterum Therapeutics PLC (ITRM)?

Iterum Therapeutics PLC (ITRM) has a market capitalisation of $ 2 Mln as on 02-Jun-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Iterum Therapeutics PLC (ITRM)?

Before investing in Iterum Therapeutics PLC (ITRM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.